Going strong since 1989

New webinar series: Deploying an electronic LMIS: Making the right choice

Over the coming weeks, TechNet-21 will be hosting a new webinar series:   Deploying an electronic LMIS: Making the right choice    This webinar series presents the leading eLMIS software and service options that are currently deployed in the field. It also explores how to prepare for a deployment and the essential steps in choosing, procuring, and implementing a robust eLMIS in a pharmaceutical supply chain.   Session #01: Introducing Bileeta LMIS Software and Services Date/time: Thursday 23rd September, 15:00 CET Register here: https://who.zoom.us/webinar/register/WN_3dDFgsDISFCGZzefXViPBw   An Introduction video to this webinar series will be posted on this website and shared on social medias on Monday 20th.   To continue the discussion or ask your questions, feel free to reply to this forum post or to join our new telegram group dedicated to Immunization Supply Chain https://t.me/joinchat/RuajXXs201pmOTdk...

Its Time to push for Intra-dermal use of COVID 19 Vaccines for wider availability and low cost

Dear Friends,                       There is an acute shortage of Covid -19 vaccines in India & developing countries. Intradermal use of COVID 19 Vaccines will result in saving up to four fifth (80%) volume of vaccines-i.e. up to five  individuals can be vaccinated by ID dose(0.1mL) as against one individual by   IM dosage(0.5mL) of the vaccine. Rabies vaccines (PCECV &PVRV) ordinarily given by IM route were also found to be equally efficacious and safe by ID route as lifesaving in Rabies post – exposure prophylaxis (PEP). Recent studies underlines the feasibility of administering COVID vaccines by ID route and having promising results in mRNA-1273 vaccine[i] and ChAdOx1 Vaccine[ii] (COVISHIELD) as well as ZyCoV-D, a DNA vaccine[iii]. We also expect that intradermal use of COVID vaccines may have lesser systemic side effects  like micro cloting events etc. It is high time we think of doing large sca...

Inter Disciplinary Collaboration: ILR & Rights 2 be observed before vaccination

Dear viewers: I proudly wish to share the following highlights of my presentation in the 8th Bengaluru Pedicon 2021 held at BMRCI [Bengaluru Medical College Research Center & Institution] Karnataka on 18th Sep 2021 organized by IAP BPS. Many of the Pediatricians and vaccination service providers especially in the private sector have lot of gaps in the operational aspects of vaccination services. One simple solution is to share the 7 universal Rights of CDC to be observed for vaccine administration blended with key messages and COVID-19 compatible guidelines. The participants were keen to know about the proper usage of ILR [Ice Lined Refrigerator] in maintaining the potency of vaccines, in need of a standard immunization card for an unambiguous vaccination schedule, about open-vial policy [MDVP] and the like. Literature on the right cold chain equipments are already available along with storage code as per gradient of heat and freeze sensitivity but they wanted to know about the ...

Webinar #8: Pfizer COVID-19 Vaccine: Planning and Implementation (WHO series on Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines)

The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (WHE) are partnering with Project ECHO of the University of New Mexico (UNM), UNICEF, and TechNet-21 to host a series of 15 sessions that align with countries’ immediate and medium-term needs. Webinar series topic: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines  The objectives of this webinar series are to optimize the use of existing resources and technical assistance through sharing of guidance, tools, resources, learnings, and best practices to support costing, budgeting, and financing of C19 immunization programs by: providing technical assistance on the use of C19 tools, guidance, resources, and trainings on costing, budgeting and financing, including the use of the updated CVIC tool version 2.2; sharing best practices in a community of practice on key challenges, benefits, and use of costing and budgeting to...

Webinar #7: Regional approach to support COVID-19 vaccination costing and budgeting in American and European countries

The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (WHE) are partnering with Project ECHO of the University of New Mexico (UNM), UNICEF, and TechNet-21 to host a series of 15 sessions that align with countries’ immediate and medium-term needs. Webinar series topic: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines  The objectives of this webinar series are to optimize the use of existing resources and technical assistance through sharing of guidance, tools, resources, learnings, and best practices to support costing, budgeting, and financing of C19 immunization programs by: providing technical assistance on the use of C19 tools, guidance, resources, and trainings on costing, budgeting and financing, including the use of the updated CVIC tool version 2.2; sharing best practices in a community of practice on key challenges, benefits, and use of costing and budgeting to...

Mini-cPIE (COVID-19 vaccination IAR) Clinic 2: Experience Sharing and Lessons Learned

  As countries conduct mini COVID-19 vaccine Post-Introduction Evaluation (mini-cPIE), also called the COVID-19 Vaccination Intra-Action Review (IAR), to review and adjust their COVID-19 vaccine roll-out, WHO will be hosting regular clinics for countries to share learnings with peer countries.  Countries that have already conducted a mini-cPIE will be invited to share their experiences, while countries interested in conducting a mini-cPIE can have the opportunity to directly connect with these countries to seek advice and ask questions they may have, including practical tools and tips for the preparation, conduct and follow-up of a mini-cPIE. Countries can also use these clinics to propose new tools they deem useful or request technical support from WHO. This webinar is the second of the series of clinics that will be held in the coming months as countries review the early phase of their vaccine roll-out using the WHO IAR (mini-cPIE) tools.   When: Tue 21...

Johns Hopkins Launches ‘Vira’ Vax Chatbot

Johns Hopkins Launches ‘Vira’ Vax Chatbot COVID-19 vaccination is lagging in young adults nationally. Vira, the Vax Chatbot is designed to support and meet young people where they are with simple answers to common COVID-19 vaccine questions. Vira is adaptive, learning by listening to your questions and feedback to help scientists respond to emerging questions. Vira was developed by the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health with experts from the Bloomberg School's Department of International Health and Johns Hopkins Whiting School of Engineering. Vira’s knowledge base from Johns Hopkins vaccine scientists was developed with support from the COVID-19 Training Initiative, with funding from Bloomberg Philanthropies. VaxChat, powered by IBM, was inspired by previous research that showed automated chatbots using AI can effectively communicate credible information and support health behavior changes. Vira can help health workers or ...

New dedicated Pfizer BioNTech COVID-19 Vaccine Resource Page

As COVID-19 Vaccine roll out is coming to speed, a dedicated Pfizer BioNTech COVID-19 Vaccine Resource Page is now available at TechNet 21. The page was developed to serve as a one-stop-shop that allows members to have easy access to available resources in different formats about wider-range of topics related Pfizer BioNTech COVID-19 Vaccine. The list of resources included in this page will be updated as new resources becomes available. The Pfizer BioNTech COVID-19 Vaccine Resource Page also provides a forum for people to share their experiences, ask questions, and share information about Pfizer BioNTech COVID-19 Vaccine.

We hope you will find this page useful. 

Link to the Pfizer BioNTech COVID-19 Vaccine Resource Page: https://www.technet-21.org/en/topics/pfizer-biontech-covid-vax 

Webinar #6: Process of planning, costing and budgeting in African region (WHO series on Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines)

The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (WHE) are partnering with Project ECHO of the University of New Mexico (UNM), UNICEF, and TechNet-21 to host a series of 15 sessions that align with countries’ immediate and medium-term needs. Webinar series topic: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines  The objectives of this webinar series are to optimize the use of existing resources and technical assistance through sharing of guidance, tools, resources, learnings, and best practices to support costing, budgeting, and financing of C19 immunization programs by: providing technical assistance on the use of C19 tools, guidance, resources, and trainings on costing, budgeting and financing, including the use of the updated CVIC tool version 2.2; sharing best practices in a community of practice on key challenges, benefits, and use of costing and budgeting to...

Course Announcement: Storytelling for Change

Storytelling for Change A Self-Paced Online Training for Immunization & Other Health Care Professionals Sign Me Up! [use invite code: sfchange2021] Deadline to Register: Monday, September 13 “The day I finished this course, I was asked to present at a national executive meeting. Using the narrative style, all that I could hear after the end was a powerful applause I’ve never received during a presentation.” Boost Community Member & Storytelling for Change Alumni The Boost Community, in partnership with People Power Health, is pleased to announce that we will again be offering a 5-week self-paced online (via mobile phone) course, Storytelling for Change, to Boost Community members starting Monday, September 13. Why does storytelling matter? The era of COVID-19 coupled with the rise of digital communication and social media has amplified messages of vaccine misinformation and disinformation, contributing to diminishing confiden...